Barrow Robert

SEC CIK
0001897557

Latest role at each company

Trades

Every Form 4 that lists Barrow Robert as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
DFTXDefinium Therapeutics, Inc.Sep 4, 20269:30 PM ETSep 3, 2026Barrow RobertChief Executive OfficerSSaleCommon Shares−19.02K$37.94−$721.73K1.49M−1.3%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Jun 26, 2026Jun 25, 2026Barrow RobertChief Executive OfficerSSaleCommon Shares−29.21K$45.03−$1.32M1.1M−2.6%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Mar 26, 2026Mar 25, 2026Barrow RobertChief Executive OfficerSSaleCommon Shares−24.43K$18.47−$451.24K752.45K−3.1%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Dec 29, 2025Dec 26, 2025Barrow RobertChief Executive OfficerSSaleCommon Shares−25.79K$13.15−$339.15K778.48K−3.2%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Sep 26, 2025Sep 25, 2025Barrow RobertChief Executive OfficerSSaleCommon Shares−25.8K$9.77−$252.04K804.27K−3.1%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Jun 26, 2025Jun 25, 2025Barrow RobertChief Executive OfficerSSaleCommon Shares−26.49K$6.80−$180.14K830.07K−3.1%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Mar 26, 2025Mar 25, 2025Barrow RobertChief Executive OfficerSSaleCommon Shares−21.21K$6.74−$142.94K856.56K−2.4%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Dec 27, 2024Dec 26, 2024Barrow RobertChief Executive OfficerSSaleCommon Shares−19.11K$7.43−$141.96K526.67K−3.5%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Sep 25, 2024Sep 25, 2024Barrow RobertChief Executive OfficerSSaleCommon Shares−19.77K$5.98−$118.23K545.77K−3.5%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Aug 20, 2024Aug 19 – Aug 20, 2024Barrow RobertChief Executive OfficerPPurchaseCommon Shares+1K$6.215+$6.22K565.54K+0.2%SEC
DFTXDefinium Therapeutics, Inc.Jun 25, 2024Jun 25, 2024Barrow RobertChief Executive OfficerSSaleCommon Shares−15.66K$7.22−$113.06K564.54K−2.7%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Mar 26, 2024Mar 25, 2024Barrow RobertChief Executive OfficerSSaleCommon Shares−16.52K$9.50−$156.93K580.2K−2.8%SEC10b5-1
DFTXDefinium Therapeutics, Inc.Dec 26, 2023Dec 26, 2023Barrow RobertChief Executive OfficerSSaleCommon Shares−13.24K$3.63−$48.05K596.72K−2.2%SEC
DFTXDefinium Therapeutics, Inc.Sep 25, 2023Sep 25, 2023Barrow RobertChief Executive OfficerSSaleCommon Shares−13.5K$3.5761−$48.27K611.73K−2.2%SEC
DFTXDefinium Therapeutics, Inc.Jun 27, 2023Jun 27, 2023Barrow RobertChief Executive OfficerSSaleCommon Shares−15.5K$3.2009−$49.62K623.46K−2.4%SEC
DFTXDefinium Therapeutics, Inc.Mar 2, 2023Mar 1, 2023Barrow RobertChief Executive OfficerSSaleCommon Shares−8.27K$3.51−$29.04K238.96K−3.3%SEC
DFTXDefinium Therapeutics, Inc.Dec 22, 2022Dec 21, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−3.86K$2.69−$10.39K247.23K−1.5%SEC
DFTXDefinium Therapeutics, Inc.Oct 25, 2022Oct 25, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−1.21K$2.81−$3.39K251.09K−0.5%SEC
DFTXDefinium Therapeutics, Inc.Oct 18, 2022Oct 18, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−1.22K$3.11−$3.79K252.3K−0.5%SEC
DFTXDefinium Therapeutics, Inc.Sep 27, 2022Sep 26, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−1.26K$5.51−$6.96K253.52K−0.5%SEC
DFTXDefinium Therapeutics, Inc.Sep 19, 2022Sep 16, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−1.35K$7.26−$9.8K254.78K−0.5%SEC
DFTXDefinium Therapeutics, Inc.Sep 1, 2022Aug 31, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−1.23K$11.67−$14.33K256.13K−0.5%SEC
DFTXDefinium Therapeutics, Inc.Aug 17, 2022Aug 16, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−20.35K$0.68−$13.84K3.86M−0.5%SEC
DFTXDefinium Therapeutics, Inc.Jul 26, 2022Jul 25, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−18.68K$0.69−$12.89K3.88M−0.5%SEC
DFTXDefinium Therapeutics, Inc.Jul 18, 2022Jul 18, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−19.39K$0.70−$13.57K3.9M−0.5%SEC
DFTXDefinium Therapeutics, Inc.Jun 28, 2022Jun 27, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−36.76K$0.70−$25.73K3.92M−0.9%SEC
DFTXDefinium Therapeutics, Inc.Jun 21, 2022Jun 16, 2022Barrow RobertChief Executive OfficerSSaleCommon Shares−21.28K$0.70−$14.89K3.96M−0.5%SEC
DFTXDefinium Therapeutics, Inc.May 26, 2022May 25, 2022Barrow RobertChief Executive OfficerSSaleSubordinate Voting Shares−18.42K$0.77−$14.18K3.98M−0.5%SEC
DFTXDefinium Therapeutics, Inc.May 19, 2022AmendedMay 18, 2022Barrow RobertChief Executive OfficerSSaleSubordinate Voting Shares−18.95K$0.71−$13.45K4M−0.5%SEC